UiPath Stock Falls 17% Despite Revenue Beat on Subscription Fears

UiPath shares plunged 16.63% following its fiscal Q2 2027 earnings release on September 3, despite the automation software company beating revenue expectations and raising full-year guidance. The sharp reversal—PATH stock initially jumped nearly 10% before cratering—signals investor concern about slowing subscription growth as large enterprise software vendors push into AI agent orchestration.

The company reported revenue of $410 million for the three months ending July 31, up 13% year-over-year and ahead of the $397.8 million analyst consensus. Management raised full-year revenue guidance to a range of $1.789 billion to $1.794 billion, up from a prior forecast of $1.776 billion to $1.781 billion.

Why it matters

UiPath commands an estimated 35% to 57% market share in robotic process automation, but its competitive moat faces a direct challenge. As Salesforce, ServiceNow, and other established enterprise platforms embed agentic AI capabilities directly into their products, the need for a standalone orchestration vendor diminishes. The subscription slowdown suggests customers may be waiting to see whether integrated solutions from their existing software providers can match UiPath's capabilities—a trend that could fundamentally reshape the automation market.

Subscription growth stalls

The troubling metric buried in the earnings report: net new annual recurring revenue fell to $37 million in Q2, down from $49 million in Q1 and $70 million in Q4 2026. This sequential decline indicates fewer new customers are signing up for UiPath subscriptions, according to CMC Markets, which first reported the analysis.

Total ARR reached $1.94 billion, growing 12% year-over-year, while the net retention rate stood at 109%, meaning existing customers increased spending by 9% compared to the prior year. But the deceleration in new customer acquisition overshadowed these otherwise solid metrics.

Competitive pressure intensifies

Salesforce and Anthropic announced Claudeforce in late August, allowing Salesforce CRM users to connect directly to Claude AI. Analysts view the move as Salesforce pushing deeper into AI agent orchestration—territory UiPath has dominated through its RPA leadership.

Canaccord Genuity analyst Kingsley Crane downgraded UiPath to 'hold' from 'buy' following the results, writing that "the competitive landscape is intensifying quickly, perhaps faster than reported numbers are capable of showing." He raised his price target to $17, implying 11.92% upside from the $15.19 closing price on September 4.

BofA analyst Koji Ikeda maintained an 'underperform' rating, questioning "whether AI is a tailwind that will result in meaningful ARR growth acceleration."

Product expansion and valuation

UiPath launched Maestro Case in June, an automation platform for handling unpredictable business processes like customer disputes and fraud investigations. Early deployments reportedly increased cases resolved without human intervention three to five times while reducing average handling time by 60% to 80%.

The company trades at a forward price-to-earnings ratio of 17.67 and forward price-to-sales ratio of 4.23, roughly in line with Salesforce but well below ServiceNow's premium valuation. UiPath's estimated sales growth of 11.13% for the current fiscal year and 8.42% for next year trails ServiceNow's projected growth of 22.15% and 18.76%, respectively.

CEO Daniel Dines told CNBC in late 2025 that the company sees "very solid demand" for agentic AI, calling current interest levels unprecedented since the early days of RPA. An investor day scheduled for September 22 may provide more detail on plans to reaccelerate subscription growth.

This analysis was originally reported by CMC Markets.